
Bringing a pharmaceutical product to market doesn’t always mean starting from scratch. Leveraging an existing ANDA, optimizing a legacy manufacturing process, or transferring an approved product may offer a faster, more cost-effective path to commercialization. Read the article here.
Innovative Ways to Expand Your Brand Portfolio and Bring New Products to Market
Bringing a pharmaceutical product to market doesn’t always mean starting from scratch. Leveraging an existing ANDA, optimizing a legacy manufacturing process, or transferring an approved product may offer a faster, more cost-effective path to commercialization.
In this Contract Pharma article, Aaron Dely, Vice President of Research & Development at PLD Pharma Services, explores four commercialization strategies and the technical, regulatory, and financial considerations that influence each decision. Through real-world examples, he demonstrates how the right combination of formulation expertise, regulatory knowledge, and manufacturing capabilities can help pharmaceutical companies accelerate product launches while reducing development costs and risk.
Discover how choosing the right commercialization pathway can give your next product a competitive advantage.